Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for hemodynamic response in hypertensive intubation
NCT03204006Completed
- Sponsor
- Assiut University
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in hypertension (HTN) (2 arms), sponsored by Assiut University. Primary endpoint: Heart Rate. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03204006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204006.